TDP-43 was subsequently found to be the major constituent of pathogenic aggregates in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) neuropathology (Arai et al., 2006; Neumann et al., 2006). Here, TARDBP is linked to amyotrophic lateral sclerosis.